Which factors causes Lung Cancer?

Smoking: Smoking cigarettes is the leading cause of lung cancer, accounting for up to 90% of all cases.

Second-hand Smoke: Second-hand smoke from cigarettes, cigars, or pipes contains many of the same cancer-causing chemicals as first-hand smoke, and can also increase the risk of lung cancer.

Exposure to Radon: Radon is a radioactive gas found in some homes, and it can increase the risk of lung cancer.

Exposure to Asbestos: People who work in certain occupations, such as construction or shipbuilding, may be exposed to asbestos, a type of mineral fibre that can increase the risk of lung cancer.

Air Pollution: Long-term exposure to air pollution, particularly in cities, can increase the risk of lung cancer.

Genetics: Having a family history of lung cancer increases the risk of developing the disease.

Factors Influencing the Global Growth:

The global lung cancer surgery industry is witnessing robust growth due to numerous factors. Firstly, the increasing prevalence of lung cancer is a major factor driving growth. With the increasing prevalence of smoking and other environmental factors, the risk of lung cancer has risen steadily. Moreover, advances in treatments such as robotic surgery and the availability of minimally invasive techniques are also driving the industry’s growth.

Additionally, the growing acceptance of personalized medicine and the development of targeted therapies are also driving growth. Furthermore, the increasing awareness among patients, healthcare professionals, and governments about the importance of early diagnosis and treatment of lung cancer is also driving the growth of the industry. Other factors such as the increasing healthcare expenditure, rising investments in research and development, and the increasing demand for cost-effective treatments are also contributing to the growth of the industry.

Download PDF Brochure for More Details..!

Why Tech Advancements are Necessary?

Tech advancements are necessary in the Lung Cancer surgery industry for a variety of reasons. First, advancements in technology can help surgeons to more accurately diagnose lung cancer and quickly identify potential tumors or other anomalies.

Additionally, advances in surgical techniques, such as robotic-assisted surgery and 3D printing, can help surgeons to more accurately and safely remove tumors, as well as reduce the risk of complications and improve the overall recovery time. Finally, technological advancements can also help to improve the accuracy of imaging tests and diagnostic tools, allowing for the earlier detection and treatment of lung cancer.

Global Geographical Growth Scenario:

The global geographical growth dynamics of the lung cancer surgery industry can be described as a combination of both the developed and developing markets. In developed countries such as the United States, Japan, and Europe, the industry has been driven by advanced technology and the availability of highly skilled surgeons. These countries have also seen an increase in the number of patients seeking lung cancer surgery.

In developing countries, the industry has been driven primarily by the rising prevalence of lung cancer in these countries and the lack of quality and affordable care. As such, there has been a rapid expansion of the industry in recent years, with many countries investing heavily in the development and expansion of the sector.

Overall, the geographical growth dynamics of the industry can be characterized as a combination of both the developed and developing markets. As the prevalence of lung cancer continues to increase in both developed and developing countries, the industry is expected to continue to grow at a rapid pace.

You Can Also Get In-Touch With Our Industry Experts to Get Your Queries Resolved

Leading Companies:

The prominent players in the global lung cancer surgery market are Accuray Inc. (US), AngioDynamics Inc. (US), Ethicon US, LLC (US), Intuitive Surgical Inc. (US), Olympus Corporation (Japan), Teleflex Incorporated (US), Ackermann Instrumente GmbH (Germany), KARL STORZ GmbH (Germany), Scanlan International Inc. (US), TROKAMED GmbH (Germany), Medtronic Plc. (Ireland), Siemens Healthcare (Germany), among others.

Ethicon Inc. (US) is the largest global lung cancer surgery market player in 2020. The company offers a wide range of endoscopy equipment, including endoscopes, mechanical endoscopy instruments, and accessories. With its strong product portfolio for endoscopy equipment, the company has established itself as one of the leading players in this market.

​Intuitive Surgical Inc. (US) is another larger player in the lung cancer surgery market, in 2020. The company has strong distribution and services channels in major markets such as the US; the company generated 68.0% of its revenue from the US alone. The company focuses on the acquisition of small players in the market space to expand and diversify its current product portfolio.